Shah Gaurav
Rocket Pharmaceuticals, Inc. · CEO
Shah Gaurav is listed in filings as CEO at Rocket Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including sale activity and purchase activity. Recent filings connect the profile to Rocket Pharmaceuticals, Inc. (RCKT). The current snapshot covers public activity from Aug 20, 2024 to May 26, 2026. Reported amounts are shown as $171.8K to $7.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $7.3k2.4k shares | SellMay 19, 2026 | $3.01 | $2.70 | |
| $9.8k2.7k shares | SellMay 13, 2026 | $3.61 | $2.70 | |
| $20k6k shares | SellFeb 18, 2026 | $3.34 | $2.70 | |
| $41k12.3k shares | SellFeb 13, 2026 | $3.31 | $2.70 | |
| $19k6.3k shares | SellNov 18, 2025 | $2.98 | $2.70 | |
| $15k2.3k shares | SellMay 20, 2025 | $6.45 | $2.70 | |
| $24k3.6k shares | SellMay 16, 2025 | $6.53 | $2.70 | |
| $102k20k shares | BuyApr 10, 2025 | $5.08 | $2.70 | |
| $172k16.3k shares | SellFeb 21, 2025 | $10.58 | $2.70 | |
| $145k11.1k shares | SellNov 21, 2024 | $13.05 | $2.70 | |
| $179k9.7k shares | SellAug 16, 2024 | $18.50 | $2.70 |